Skin cancer vaccine FDA approved by June 30, 2027?
The field · 3 outcomes
From Today's edition · Oct 24, 2026
This question asks whether an FDA-approved skin-cancer vaccine exists by June 30, 2027; the leading candidate is Moderna and Merck’s personalized mRNA melanoma vaccine, intismeran autogene (mRNA-4157/V940). On Oct. 22, 2026, AP said a major study showed the vaccine sharply reduced melanoma recurrence and that the companies were in talks with regulators about next steps. [1] That followed Reuters’ Aug. 19, 2026 report that the vaccine cut recurrence and spread in a large trial, with the companies preparing to seek U.S. approval and saying they expected a 2027 launch, and Reuters’ Jan. 20, 2026 report that five-year follow-up still showed benefit. ClinicalTrials.gov last updated the KEYNOTE-942 record on Sept. 8, 2026, showing the underlying program is still being tracked as an active clinical study. [2]
Context by Predxy AI ·
- 1. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning apnews.com
- 2. Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope | MarketScreener marketscreener.com
AI-researched background, with linked sources. It does not explain or predict market movements.
As of Nov 1, 09:35 AM UTC · Market prices are not certainties.
